Vanessa Iribarrem Avena Miranda

Dr. Vanessa Iribarrem Avena Miranda

Pós graduação em Saúde Coletiva, Universidade do Extremo Sul Catarinense, Criciúma, Santa Catarina, Brazil
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2020 in Paediatric and Perinatal Epidemiology
Verified
Journal Article
Closed access
PDF file
ABAndrea Damaso Bertoldi
Andrea Damaso Bertoldi
SRSheryl Rifas-Shiman
Sheryl Rifas-Shiman
ABAlexandra Crispim Boing
Alexandra Crispim Boing
TDTatiane Da Silva Dal-Pizzol
Tatiane Da Silva Dal-Pizzol
Vanessa Iribarrem Avena MirandaVanessa Iribarrem Avena Miranda
Vanessa Iribarrem Avena Miranda
EOEmily Oken
Emily Oken

2 December 2019 in Substance Use & Misuse
Verified
Journal Article
Closed access
BCBianca O Cata-Preta
Bianca O Cata-Preta
Vanessa Iribarrem Avena MirandaVanessa Iribarrem Avena Miranda
Vanessa Iribarrem Avena Miranda
ABAndrea Damaso Bertoldi
Andrea Damaso Bertoldi
Background: College students are susceptible to using cognitive enhancement drugs, also known as smart drugs. Objectives: estimate the prevalence of smart drug use and investigate the factors related to access and use among undergraduate students. Methods: cross-sectional study performed among all students who entered the university in 2017 using an anonymous, self-administered questionnaire. Smart drug usage was defined as taking methylphenidate, modafinil or piracetam at any point in life and in the preceding 12 months. We characterized the means of obtaining smart drugs, reasons for using and students’ residential situation. We asked students who did not use any medication if they were interested in taking it and the reasons for not using. Results: Out of 1865 respondents, 4.2% had used smart drugs in the last 12 months, and the prevalence among law students reached 14.3%. The most commonly used smart drug was methylphenidate. Among the students who did not present ADD diagnosis, the drug was obtained mostly through a friend. More than 300 students reported a desire to use some smart drug, but they did not, mainly due to the fear of side effects. Conclusions: The current study has found a variety of frequency of smart drug use among college students and has also showed that many students are willing to take some kind of cognitive enhancement drug. Therefore, it is important to discuss this issue from a public health perspective.

BLBarbara Lutz
Barbara Lutz
Vanessa Iribarrem Avena MirandaVanessa Iribarrem Avena Miranda
Vanessa Iribarrem Avena Miranda
MSMarysabel Pinto Telis Silveira
Marysabel Pinto Telis Silveira
TDTatiane Da Silva Dal-Pizzol
Tatiane Da Silva Dal-Pizzol
SMSotero Serrate Mengue
Sotero Serrate Mengue
ABAndrea Damaso Bertoldi
Andrea Damaso Bertoldi
Background: Medication use during pregnancy is a common practice that has been increasing in recent years. The aim of this study is to describe medication use among pregnant women from the 2015 Pelotas (Brazil) Birth Cohort Study. Methods: This paper relies on a population-based cohort study including 4270 women. Participants completed a questionnaire about the antenatal period, including information about medication use. We performed descriptive analyses of the sample and the medications used and adjusted analyses for the use of medications and self-medication. Results: The prevalence of medication use was 92.5% (95% CI 91.7–93.3), excluding iron salts, folic acid, vitamins, and other minerals. The prevalence of self-medication was 27.7% (95% CI 26.3–29.1). In the adjusted analysis, women who had three or more health problems during pregnancy demonstrated higher use of medicines. Self-medication was higher in lower income groups and among smokers and multiparous women (three pregnancies or more). Acetaminophen, scopolamine, and dimenhydrinate were the medications most commonly used. Conclusions: This study describes the pattern of drug use among pregnant women in a population-based cohort study, with a high prevalence of self-medication. Greater awareness of the risks of self-medication during pregnancy is required, focusing on groups more prone to this practice, as well as ensuring qualified multidisciplinary prenatal care.

1 January 2021 in Epidemiologia e Serviços de Saúde
Verified
Journal Article
Open access
ASAntônio Augusto Schäfer
Antônio Augusto Schäfer
LSLeonardo Pozza Santos
Leonardo Pozza Santos
Vanessa Iribarrem Avena MirandaVanessa Iribarrem Avena Miranda
Vanessa Iribarrem Avena Miranda
CTCristiane Damiani Tomasi
Cristiane Damiani Tomasi
JSJacks Soratto
Jacks Soratto
FMFernanda Oliveira Meller
Fernanda Oliveira Meller
Resumo Objetivo: Analisar desigualdades regionais e sociais na realização de mamografia e exame citopatológico. Métodos: Estudo transversal, com dados da Vigilância de Fatores de Risco e Proteção para Doenças Crônicas por Inquérito Telefônico (Vigitel), de 2019. As variáveis de desfecho foram realização de mamografia e exame citopatológico; e as variáveis de exposição, raça/cor da pele, escolaridade e macrorregião nacional de residência. Medidas de desigualdades absolutas foram apresentadas por meio do slope index of inequality (SII) e equiplots. Resultados: Foram incluídas 23.339 mulheres. A realização de mamografia foi 5,2 pontos percentuais maior naquelas com maior escolaridade, e de exame citopatológico, 5,3 pontos percentuais menor nas mulheres de raça/cor da pele preta. A realização de mamografia e exame citopatológico foram 3,9 e 11,2 pontos percentuais maiores na região Sul, respectivamente. Conclusão: Desigualdades sociais e regionais persistem no país e afetam, principalmente, mulheres de raça/cor da pele preta, de baixa escolaridade e residentes no Nordeste brasileiro.

1 January 2022 in Cadernos de Saude Publica
Verified
Journal Article
Open access
FMFernanda de Oliveira Meller
Fernanda de Oliveira Meller
LSLeonardo Pozza Santos
Leonardo Pozza Santos
Vanessa Iribarrem Avena MirandaVanessa Iribarrem Avena Miranda
Vanessa Iribarrem Avena Miranda
CTCristiane Damiani Tomasi
Cristiane Damiani Tomasi
JSJacks Soratto
Jacks Soratto
ASAntônio Augusto Schäfer
Antônio Augusto Schäfer
O objetivo foi analisar as desigualdades econômica, racial e geográfica nos comportamentos de risco para doenças crônicas não transmissíveis dos adultos brasileiros. Estudo transversal realizado com os dados do Vigitel (Vigilância de Fatores de Risco e Proteção para Doenças Crônicas por Inquérito Telefônico) de 2019. Os comportamentos de risco analisados foram tabagismo, consumo abusivo de álcool, inatividade física, excesso de peso, consumo regular de refrigerante ou suco artificial e consumo não regular de frutas, legumes e verduras. As desigualdades nos comportamentos de risco foram avaliadas considerando escolaridade e macrorregião de moradia dos brasileiros, por meio do índice de desigualdade absoluta (slope index of inequality - SII). Gráficos equiplots também foram construídos para melhor ilustrar as desigualdades. Para todas as análises, foi utilizado o comando svy do Stata devido à complexidade do processo amostral. Foram avaliados 52.395 indivíduos. Desigualdades importantes nos comportamentos de risco para doenças crônicas não transmissíveis foram observadas: ter baixa escolaridade concentrou a grande maioria dos comportamentos de risco. Tabagismo e consumo de refrigerante foram mais observados na Macrorregião Sul do país. São necessárias políticas públicas que visem reduzir as desigualdades encontradas, permitindo a melhoria nos indicadores de saúde da população brasileira.

28 June 2021 in BMC Public Health
Verified
Journal Article
Open access
PDF file
Vanessa Iribarrem Avena MirandaVanessa Iribarrem Avena Miranda
Vanessa Iribarrem Avena Miranda
ASAntônio Augusto Schäfer
Antônio Augusto Schäfer
CTCristiane Damiani Tomasi
Cristiane Damiani Tomasi
JSJacks Soratto
Jacks Soratto
FMFernanda de Oliveira Meller
Fernanda de Oliveira Meller
MSMarysabel Pinto Telis Silveira
Marysabel Pinto Telis Silveira
Background: To guarantee prevention and adequate treatment, as required for the population to have access to health services and technologies, including medicines. The purpose of this study is to analyse the economic and regional inequalities in access to medicines for diabetes and hypertension among the adult population in Brazil. Methods: This was a cross-sectional study with adults aged 18 and over from the VIGITEL study conducted in 2019 in all Brazilian regions. Non-access to antidiabetic and antihypertensive drugs was assessed according to formal education and housing macro-region. The slope index of inequality (SII) was used to analyse absolute inequalities. Results: The total number of individuals interviewed was 52,443. Approximately 10.0% of the people with diabetes and/or hypertension reported not having access to drug treatment. The major means for having access to antihypertensive drugs, in all regions, was private pharmacies; for antidiabetics, in the North region, people had greater access through private pharmacies, while in the Northeast, Southeast and South, they had greater access through the public sector. Inequalities were found in the lack of access to medicines according to the region of residence, especially in the North region. Conclusion: The lack of access to medicines showed regional disparities, particularly in the most economically vulnerable regions.